A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Spain- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Spain201 clinical trials in Barakaldo, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on acute cerebral ischemic stroke treatments and groundbreaking studies in Parkinson's disease management, including trials of novel compounds like NEU-411 and CVN424.
These trials aim to improve patient outcomes and develop more effective treatment strategies.
Comprehensive cancer studies including treatments for metastatic prostate cancer, pancreatic adenocarcinoma, and innovative approaches in breast cancer therapy.
Focus on developing targeted therapies and improving survival rates across various cancer types.
Studies addressing COVID-19 vaccination strategies and treatments for invasive candidiasis, with particular attention to antimicrobial therapies.
These trials evaluate new therapeutic approaches and vaccine effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.